A detailed history of Kaydan Wealth Management, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Kaydan Wealth Management, Inc. holds 9,917 shares of PFE stock, worth $265,180. This represents 0.08% of its overall portfolio holdings.

Number of Shares
9,917
Previous 12,744 22.18%
Holding current value
$265,180
Previous $357 Million 19.51%
% of portfolio
0.08%
Previous 0.13%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$27.7 - $31.39 $78,307 - $88,739
-2,827 Reduced 22.18%
9,917 $287 Million
Q2 2024

Jul 11, 2024

SELL
$25.26 - $29.6 $38,875 - $45,554
-1,539 Reduced 10.78%
12,744 $357 Million
Q1 2024

Apr 12, 2024

SELL
$25.89 - $29.73 $23,559 - $27,054
-910 Reduced 5.99%
14,283 $396 Million
Q4 2023

Jan 16, 2024

SELL
$26.13 - $33.94 $47,504 - $61,702
-1,818 Reduced 10.69%
15,193 $437 Million
Q3 2023

Nov 02, 2023

SELL
$32.09 - $37.51 $10,108 - $11,815
-315 Reduced 1.82%
17,011 $564 Million
Q2 2023

Jul 17, 2023

SELL
$36.12 - $41.79 $9,680 - $11,199
-268 Reduced 1.52%
17,326 $636 Million
Q1 2023

Apr 10, 2023

SELL
$39.39 - $51.28 $11,107 - $14,460
-282 Reduced 1.58%
17,594 $718 Million
Q4 2022

Feb 06, 2023

BUY
$41.75 - $54.5 $746,323 - $974,242
17,876 New
17,876 $916 Million
Q3 2022

Feb 24, 2023

SELL
$43.76 - $53.42 $19,429 - $23,718
-444 Reduced 2.42%
17,930 $785 Million
Q2 2022

Feb 24, 2023

SELL
$46.53 - $55.17 $4,001 - $4,744
-86 Reduced 0.47%
18,374 $963 Million
Q1 2022

Feb 24, 2023

SELL
$45.75 - $56.69 $3,614 - $4,478
-79 Reduced 0.43%
18,460 $956 Million
Q4 2021

Feb 24, 2023

BUY
$41.32 - $61.25 $27,395 - $40,608
663 Added 3.71%
18,539 $1.09 Billion

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Kaydan Wealth Management, Inc. Portfolio

Follow Kaydan Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kaydan Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kaydan Wealth Management, Inc. with notifications on news.